Search Results - "I. Bielsa"

Refine Results
  1. 1
  2. 2
  3. 3

    Cutaneous Manifestations in the Context of SARS-CoV-2 Infection (COVID-19) by Carrascosa, J M, Morillas, V, Bielsa, I, Munera-Campos, M

    Published in Actas dermo-sifiliográficas (English ed.) (01-11-2020)
    “…The coronavirus 2019 (COVID-19) pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has had enormous health, economic, and social…”
    Get full text
    Journal Article
  4. 4

    Skin lesions in neurofibromatosis type 2: diagnostic and prognostic significance of cutaneous (plexiform) schwannomas by Plana‐Pla, A., García, B., Munera‐Campos, M., Catasus, N., Serra Arenas, E., Blanco, I., Castellanos Perez, E., Bielsa, I.

    “…Background Neurofibromatosis type 2 (NF2) is a genetic disease characterized by the appearance of multiple tumours in the nervous system. Cutaneous lesions are…”
    Get full text
    Journal Article
  5. 5

    Cutaneous Manifestations in the Context of SARS-CoV-2 Infection (COVID-19) by Carrascosa, J.M., Morillas, V., Bielsa, I., Munera-Campos, M.

    Published in Actas Dermo-Sifiliograficas (01-11-2020)
    “…The coronavirus 2019 (COVID-19) pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has had enormous health, economic, and social…”
    Get full text
    Journal Article
  6. 6

    Protein S deficiency revealed by skin necrosis in a patient with lupus by Plana-Pla, A, Bielsa Marsol, I, Ferrandiz Foraster, C

    Published in Lupus (01-06-2019)
    “…Protein S deficiency is rare in systemic lupus erythematosus (SLE) and is generally associated with the presence of antiphospholipid (APL) antibodies. Lack of…”
    Get full text
    Journal Article
  7. 7
  8. 8

    A novel in Vitro percutaneous penetration model : Evaluation of barrier properties with P-aminobenzoic acid and two of its derivatives by DE JAGER, Miranda, GROENINK, Wouter, I GUIVERNAU, Ruth Bielsa, ANDERSSON, Elin, ANGELOVA, Nadezhda, PONEC, Maria, BOUWSTRA, Joke

    Published in Pharmaceutical research (01-05-2006)
    “…The objective of this study was to evaluate the utility of a stratum corneum substitute (SCS) as a novel in vitro percutaneous penetration model. The SCS…”
    Get full text
    Journal Article
  9. 9
  10. 10
  11. 11

    Lupus erythematosus tumidus: a clinical and histological study of 25 cases by Rodriguez-Caruncho, C, Bielsa, I, Fernández-Figueras, M T, Roca, J, Carrascosa, J M, Ferrándiz, C

    Published in Lupus (01-06-2015)
    “…Background Lupus erythematosus tumidus (LET) is a subtype of cutaneous lupus erythematosus (CLE) that has been well characterized in recent years. However,…”
    Get full text
    Journal Article
  12. 12

    New autoantibodies in dermatomyositis by Bielsa, I

    Published in Actas dermo-sifiliográficas (01-04-2009)
    “…Dermatomyositis is an idiopathic inflammatory myopathy that affects skeletal muscle and the skin. Idiopathic inflammatory myopathies are characterized by the…”
    Get more information
    Journal Article
  13. 13

    Population-based incidence of basal cell carcinoma in a Spanish Mediterranean area by Bielsa, I., Soria, X., Esteve, M., Ferrándiz, C.

    Published in British journal of dermatology (1951) (01-12-2009)
    “…Summary Background  Considering the latitude of Spain, the reported age‐adjusted incidence rates of basal cell carcinoma (BCC) in this country, similar to…”
    Get full text
    Journal Article
  14. 14

    Lupus erythematosus tumidus: a clinical entity still being defined by Rodríguez-Caruncho, C, Bielsa, I

    Published in Actas dermo-sifiliográficas (English ed.) (01-11-2011)
    “…Lupus erythematosus tumidus (LET), a form of cutaneous lupus erythematosus that was described some years ago, has begun to receive more attention in the past…”
    Get full text
    Journal Article
  15. 15
  16. 16

    Update on the Classification and Treatment of Localized Scleroderma by Bielsa Marsol, I

    Published in Actas dermo-sifiliográficas (English ed.) (01-10-2013)
    “…Abstract Morphea or localized scleroderma is a distinctive inflammatory disease that leads to sclerosis of the skin and subcutaneous tissues. It comprises a…”
    Get full text
    Journal Article
  17. 17

    Cutaneous lymphomas showing prominent granulomatous component: clinicopathological features in a series of 16 cases by Gallardo, F, García-Muret, MP, Servitje, O, Estrach, T, Bielsa, I, Salar, A, Abella, E, Barranco, C, Pujol, RM

    “…Background  The presence of a prominent granulomatous tissue reaction in skin biopsies from primary cutaneous or systemic malignant lymphomas with secondary…”
    Get full text
    Journal Article
  18. 18

    Lupus Erythematosus Tumidus: A Clinical Entity Still Being Defined by Rodríguez-Caruncho, C, Bielsa, I

    Published in Actas dermo-sifiliográficas (English ed.) (01-11-2011)
    “…Abstract Lupus erythematosus tumidus (LET), a form of cutaneous lupus erythematosus that was described some years ago, has begun to receive more attention in…”
    Get full text
    Journal Article
  19. 19
  20. 20

    Good response of scleromyxedema and dermato-neuro syndrome to treatment with intravenous immunoglobulins by Bielsa, I, Benvenutti, F, Guinovart, R M, Ferrándiz, C

    Published in Actas dermo-sifiliográficas (English ed.) (01-05-2012)
    “…Scleromyxedema is a potentially serious disease that can have various systemic complications. One of the most frequent forms of central nervous system…”
    Get full text
    Journal Article